Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. Formed by the merger of PharmaCord and Mercalis, Valeris™ revolutionizes the path from life sciences innovation to real-life impact to build a world in which every patient gets the care they need. Valeris works on behalf of life sciences companies to improve the patient experience so that patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides the data and strategic insights, patient support services and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina and Jeffersonville, Indiana. To learn more about Valeris, please visit www.valeris.com.

As a Vice President, FP&A and Business Performance, you will join our team on a journey to help eliminate barriers for patients, increase their access to medications, and help them receive lifesaving treatments while working in an environment that nurtures you.

As the Vice President, FP&A and Business Performance, you will own the forecasting and business accountability pillar of the Finance organization. You will be responsible for the budget, the monthly and full-year forecast, monthly P&L reviews, variance analysis, KPI and executive reporting, and finance partnering with department and business-unit leaders. You will institutionalize a recurring forecast and close-review cadence and drive monthly P&L accountability across the enterprise. This position reports directly to the Chief Financial Officer.

Key Responsibilities:

Own the annual budget process and the rolling monthly and full-year forecast.
Run the monthly business review meetings and monthly close-review cadence with clear owners and outputs.
Lead variance analysis against budget, forecast, and prior period, and drive corrective action plans to closure.
Institutionalize the variance standard, including explanations and action plans for SG&A variances over the agreed threshold.
Build executive and Board reporting packages that clearly state performance, risks, opportunities, and actions.
Partner with department and business-unit leaders to institutionalize P&L ownership and accountability.
Develop and maintain enterprise KPI reporting and management dashboards.
Drive forecast accuracy improvement and strengthen the link between operational drivers and financial outcomes.
Partner with Accounting on the close calendar and with Strategic Finance on capital and scenario planning.
Support business cases and financial modeling for material investments and strategic initiatives.
Identify and apply automation and AI-enabled approaches to forecasting, variance analysis, and reporting, continuing to progress on automation already initiated.
Lead, mentor, and develop the FP&A team and finance business partners.
Utilize Valeris’ values as the driving force behind the team’s success.
Maintain on-time adherence to training deadlines for all corporate policies and procedures.
Ensure all SOPs are followed with consistency.
Perform additional tasks or projects as assigned.

Qualifications:

BA or BS in Finance, Accounting, Economics, or a related field required.
MBA, CFA, or CMA a plus.
10+ years of FP&A or corporate finance experience, including 5+ years in a leadership role.
Advanced financial modeling and analytical skills; expert in building executive-grade reporting.
Hands-on experience with ERP and EPM/planning tools (e.g., Adaptive, Anaplan, Hyperion, or similar).
Demonstrated success institutionalizing a forecast and close-review cadence and driving P&L accountability.
Strong business partnering, influence, and executive communication skills.
Experience in life sciences, healthcare services, or another complex, multi-business-unit environment preferred.
Comfort applying automation and AI tools to improve cycle time and forecast accuracy a plus.

Physical Demands & Work Environment

While performing the duties of this job, the employee is regularly required to talk or hear. The employee is frequently required to sit for long periods of time, use hands to type, handle or feel; and reach with hands and arms. Prefer candidates who can type at least 35 words per minute with 97% accuracy.
Although very minimal, flexibility to travel as needed is preferred.
This job operates in a professional office environment. This role routinely uses standard office equipment such as computers, phones, photocopiers, etc.

Why Work for Valeris?

We’re committed to supporting the well-being and success of our team members. As part of our organization, full-time employees can expect:

Medical, dental, and vision plans, including HSA- and FSA-eligible options, with Valeris contributing toward premium costs
Additional health support, including telehealth and Employee Assistance Program (EAP) services
Company match on Health Savings Account contributions
Free Basic Life and AD&D coverage equal to your annual earnings, with a minimum of $50,000 and a maximum of $300,000
Company-paid Short-Term Disability coverage, with the option to purchase Long-Term Disability
401(k) Retirement Savings Plan with 100% match on the first 5% you contribute, with immediate vesting
Paid Time Off (PTO) and Sick Leave to support work-life balance
Team members receive nine paid holidays plus two floating holidays
Opportunities for advancement in a company that supports personal and professional growth
A challenging, stimulating work environment that encourages new ideas
Work for a company that values diversity and makes deliberate efforts to create an inclusive workplace
A mission-driven, inclusive culture where your work makes a meaningful impact

Any offer of employment is contingent upon the successful completion of a background check and, depending on the position, a drug screen in accordance with company standards. Please note that this job description is not intended to be an exhaustive list of all duties, responsibilities, or activities associated with the position. Responsibilities and tasks may be modified at any time, with or without notice.

Our Commitment to Equal Opportunity

At Valeris, we don’t just accept difference – we celebrate it, support it and we thrive on it for the benefit of our employees, our products and our community. Valeris is proud to be an equal opportunity employer.

About the company

Valeris delivers end-to-end life sciences commercialization support for biopharmaceuticals, spanning strategy, patient access, and provider engagement. Its platform combines patient access and affordability programs, payer reimbursement support, data insights, and clinician engagement tools to streamline the patient journey. By integrating PharmaCord’s patient services with Mercalis’s technology and market access infrastructure, Valeris positions itself as an independent, scalable partner in patient access and support. Backed by Permira and Odyssey Investment Partners, Valeris helps clients navigate market access, speed therapy adoption, improve patient outcomes, and generate actionable commercialization insights.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Get referred to Valeris

See people who can refer or advise you

Simplify's Take

What believers are saying

January 20, 2026 results said Valeris exceeded fiscal 2025 goals after the merger.
July 27, 2026, SaveOn SP removed several brands, restoring full copay value.
April 29, 2026 Fuze Health collaboration expands digital pharmacy and access workflows.

What critics are saying

Payers keep deploying medical benefit maximizers; Valeris named 200 targeted brands on Policy Reporter.
Vantage centralizes PHI, creating HIPAA breach and model-error liability during 2026 rollouts.
Integration can stall service quality, and lost manufacturer contracts would crush the merged platform.

What makes Valeris unique

Valeris combines Mercalis market access with PharmaCord patient support across 500-plus biopharma customers.
Its June 16, 2026 Vantage platform adds real-time compliance guidance and 100% interaction QA.
Lauren Cole and Jeff Crowther strengthen strategy and revenue execution under Scott Filosi.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Life Insurance
Disability Insurance
401(k) Company Match
Paid Vacation
Paid Sick Leave
Paid Holidays

Company News

PR Newswire

Sep 15th, 2026

Valeris hires Jeff Crowther as Chief Revenue Officer to drive growth strategy

Valeris, a life sciences commercialisation partner, has appointed Jeff Crowther as Chief Revenue Officer. Crowther brings over 30 years of commercial leadership experience across marketing, sales, market access, and business development, with expertise spanning oncology, hematology, CNS, gastroenterology, and infectious diseases. He joins from Syndax Pharmaceuticals, where he served as SVP, Commercial, building the oncology biotech's inaugural commercial functions ahead of its first two asset launches. Previously, at SK Life Science, Crowther built the commercial infrastructure behind XCOPRI, the most successful adult partial-onset seizure product launch in the US in over a decade. Crowther will report to Chief Commercial Officer Scott Filosi and join the Valeris Executive Committee. The appointment reflects Valeris's continued investment in growth and innovation whilst maintaining focus on patient-centred strategic decisions.

PR Newswire

Aug 18th, 2026

Valeris appoints Lauren Cole as chief strategy officer to strengthen patient services integration

Valeris, a commercialisation partner for life sciences companies, has appointed Lauren Cole as Chief Strategy Officer. Cole will report to Chief Commercial Officer Scott Filosi and focus on integrating market access, patient services, and commercial strategy. Cole brings extensive experience in patient services and market access strategy. Most recently, she served as Vice President of Patient Services at Verona Pharma, a Merck subsidiary, where she led a patient services unit that improved access outcomes. Previously, she held the position of Executive Director of Patient Services at Ardelyx, designing patient services solutions for nephrology medications. Valeris provides commercialisation solutions to over 500 life sciences customers and has supported millions of patients with access and affordability programmes.

PR Newswire

Jun 16th, 2026

Valeris launches Vantage™ platform to help patient support teams navigate complex therapy journeys in real time

Valeris, a life sciences commercialisation partner, has launched Valeris Vantage, an operational intelligence platform designed to help patient support teams navigate complex healthcare programmes. The platform provides real-time guidance during patient interactions, surfacing programme-specific information, compliance prompts and workflow requirements as conversations unfold. Vantage uses AI to monitor conversations and deliver contextual support, helping case managers and nurses handle growing programme complexity whilst maintaining focus on patient care. The platform also provides comprehensive quality assurance, analysing 100% of interactions against compliance criteria. In a recent implementation with a specialty biopharmaceutical product, Vantage contributed to a 98.6% quality assurance score, zero patient safety errors and a 65% reduction in call errors. The platform aims to accelerate staff training, improve consistency and scale institutional knowledge across support programmes.

Valeris

Jun 16th, 2026

Valeris introduces Valeris Vantage(TM), combining real-time guidance and data insights to help patient support teams navigate complexity and improve outcomes.

Valeris introduces Valeris Vantage(TM), combining real-time guidance and data insights to help patient support teams navigate complexity and improve outcomes. June 16, 2026 Tuesday, June 16, 2026 JEFFERSONVILLE, IN and MORRISVILLE, NC - Valeris, a fully integrated life sciences commercialization partner, announced today the launch of Valeris Vantage(TM), a new Operational Intelligence Platform designed to help patient support teams navigate increasingly complex patient access and support programs with greater confidence, consistency, and efficiency. As part of Valeris's commitment to delivering industry-leading innovation, Vantage was developed to improve patient outcomes and experiences while driving measurable improvements in operational performance across the therapy journey.

PR Newswire

Apr 29th, 2026

Valeris and Fuze Health agree to collaborate on advancing A Connected and performance-driven Patient Access model.

Valeris and Fuze Health agree to collaborate on advancing A Connected and performance-driven Patient Access model. Apr 29, 2026, 10:00 ET Collaboration Aims to Accelerate Time to Therapy, Improve Patient Access, and Deliver Measurable Outcomes for Biopharmaceutical Partners JEFFERSONVILLE, Ind. and SAN FRANCISCO, April 29, 2026 /PRNewswire/ - Valeris, a fully integrated life sciences commercialization partner, and Fuze Health, a technology-powered health services company, have agreed to collaborate to modernize the patient access model by integrating digital pharmacy capabilities with access, affordability, and patient support services. The hub services leaders made the announcement at Asembia's AX26 Summit in Las Vegas. The collaboration reflects the companies' shared vision to transform market access in life sciences, powered by technology and data-driven insights that enable smarter strategies and better patient outcomes. Together, Valeris and Fuze Health aim to deliver a connected, efficient, and scalable model that improves speed, coordination, and performance across the patient journey. "At Valeris, our mission is to support patients every step of the way, making access to care faster, easier, and backed by unwavering support," said Robert Truckenmiller, Chief Executive Officer of Valeris. "This collaboration is a meaningful step toward that mission and our broader vision of bringing together digital pharmacy and patient access in an integrated model that reduces delays, improves coordination, and helps patients start and stay on therapy." "Fuze Health and Valeris share a commitment to expanding access to critical therapies and innovating the patient experience," said Paul Greenall, Chief Executive Officer of FuzeRx, the pharmacy services division of Fuze Health. "Together with Valeris, our goal is to deliver an augmented suite of solutions to ensure pharmaceutical manufacturers can enhance their provider and patient experiences." A Connected and Accountable Approach to Patient Access At the core of the collaboration is a coordinated operating model that brings together digital pharmacy workflows and patient access services into a unified, performance-driven experience. * Through its Access+ hub services platform, Fuze Health will lead digital pharmacy operations, including prescription intake, real-time eligibility and coverage checks, and patient engagement through automated, data-driven platforms. * Valeris will deliver comprehensive patient access services, including benefit verification across pharmacy and medical benefits, prior authorization and appeals support, affordability solutions, and patient support services. * Together, the organizations will streamline coordination across the patient journey, with greater visibility and accountability for patient outcomes. Delivering Measurable Impact Across Four Core Areas: Accelerating Time to Therapy: Faster benefit verification and streamlined prior authorization processes to reduce delays and improve turnaround times from prescription to therapy initiation. Improving Access, Affordability, and Outcomes: Integrated copay, affordability, and patient support services designed to reduce patient drop-off, increase therapy starts, and improve overall program performance. Delivering a Connected and Proactive Model: Tighter integration between digital pharmacy and patient services, combined with automation and AI to improve visibility, coordination, and speed at scale. Positioned for a Changing Market As the access landscape rapidly evolves, this collaboration aims to deliver operational performance and forward-looking innovation by combining digital enablement, data-driven insights, and patient-centric services to create a responsive and effective access model. About Valeris: Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company works on behalf of life sciences companies to improve the patient experience so that patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris administers commercialization solutions for more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina and Jeffersonville, Indiana. To learn more about Valeris, please visit www.valeris.com. About Fuze Health Fuze Health is a technology-powered healthcare solutions company dedicated to transforming patient experiences and enabling healthcare partners - including health plans, life sciences companies, employers and care providers - to excel in an outcomes-focused system. By connecting diagnostic and genomic testing, pharmacy services and care support, Fuze Health enables patients to access the care they need and healthcare partners to achieve better outcomes across the care journey. To learn more about Fuze Health, visit www.fuzehealth.com. Media Contacts Valeris: Landy Townsend VP, Marketing & Communications Valeris [email protected] SOURCE Valeris

Valeris

Vice President - Financial Planning and Analysis and Business Performance

About the job

Physical Demands & Work Environment

Why Work for Valeris?

Our Commitment to Equal Opportunity

About the company

Get referred to Valeris

Simplify's Take

What believers are saying

What critics are saying

What makes Valeris unique

Benefits

Company News